Nextech CEO Evan Gappelberg Buys 250,000 Shares of Company Stock

    NEXT STORY
    Vaxil Provides Update on USAMRIID, Oral Experiment and Other General Business Matters
    PREV STORY
    European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novartis receives positive CHMP opinion for Kesimpta®* (ofatumumab), a self-administered treatment for adult patients with relapsing multiple sclerosis

    author_avatar
    NASDAQ Market News

    InteloMed, Inc. to Exhibit Non-Invasive Monitoring System for Assessing Dialysis Tolerance at the American Society of Nephrology Annual Kidney Week

    PITTSBURGH, PA--(Marketwired - Nov 16, 2016) - InteloMed, Inc., a leader in the development ...

    author_avatar
    NASDAQ Market News

    Argos Therapeutics Enters into Strategic Research Agreement with Adaptive Biotechnologies

    DURHAM, N.C., June 15, 2016 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), an immuno-oncology ...

    author_avatar
    NASDAQ Market News